ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer
Language English Country Great Britain, England Media electronic-print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
37802631
DOI
10.1183/13993003.00533-2023
PII: 13993003.00533-2023
Knihovny.cz E-resources
- MeSH
- Early Detection of Cancer methods MeSH
- Expressed Sequence Tags MeSH
- Humans MeSH
- Lung Neoplasms * diagnostic imaging MeSH
- Incidental Findings MeSH
- Tomography, X-Ray Computed methods MeSH
- Practice Guidelines as Topic * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted cancer screening programme. The imperative now is to ensure that implementation follows an evidence-based process that will ensure clinical and cost effectiveness. This European Respiratory Society (ERS) task force was formed to provide an expert consensus for the management of incidental findings which can be adapted and followed during implementation. METHODS: A multi-European society collaborative group was convened. 23 topics were identified, primarily from an ERS statement on lung cancer screening, and a systematic review of the literature was conducted according to ERS standards. Initial review of abstracts was completed and full text was provided to members of the group for each topic. Sections were edited and the final document approved by all members and the ERS Science Council. RESULTS: Nine topics considered most important and frequent were reviewed as standalone topics (interstitial lung abnormalities, emphysema, bronchiectasis, consolidation, coronary calcification, aortic valve disease, mediastinal mass, mediastinal lymph nodes and thyroid abnormalities). Other topics considered of lower importance or infrequent were grouped into generic categories, suitable for general statements. CONCLUSIONS: This European collaborative group has produced an incidental findings statement that can be followed during lung cancer screening. It will ensure that an evidence-based approach is used for reporting and managing incidental findings, which will mean that harms are minimised and any programme is as cost-effective as possible.
Azienda Ospedaliero Universitaria Maggiore della Carità di Novara Novara Italy
Bayer AG Research and Development Pharmaceuticals Radiology Berlin Germany
Christian Albrechts Universität zu Kiel Faculty of Medicine Kiel Germany
Cochin Hospital APHP Radiology Department Paris France
European Lung Foundation Tipton UK
Galway Clinic Doughiska Galway Ireland
German Center for Lung Research DZL Translational Lung Research Center TLRC Heidelberg Germany
HELIOS Klinikum Emil von Behring GmbH Lungenklinik Heckeshorn Berlin Germany
Humanitas Research Hospital Division of Thoracic and General Surgery Rozzano Italy
Inselspital Universitatsspital Bern Radiation Oncology Bern Switzerland
Institute of Tuberculosis and Lung Diseases Warsaw Genetics and Clinical Immunology Warsaw Poland
Kantonsspital Sankt Gallen Radiation Oncology Sankt Gallen Switzerland
Kliniken Maria Hilf GmbH Monchengladbach Nordrhein Westfalen Germany
Medical Centre Leeuwarden Department of Respiratory Medicine Leeuwarden The Netherlands
National Koranyi Institute of Pulmonology Department of Radiology Budapest Hungary
Nottingham University Hospitals NHS Trust Nottingham UK
Radboud University Nijmegen Medical Center Department of Radiology Nijmegen The Netherlands
Royal Brompton and Harefield NHS Foundation Trust Radiology London UK
Sotiria General Hospital of Chest Diseases of Athens Respiratory Medicine Athens Greece
St James's University Hospital Department of Thoracic Surgery Leeds UK
UMCG Groningen The Netherlands
Universitaire Ziekenhuizen Leuven Radiology Leuven Belgium
UniversitatsKlinikum Heidelberg Heidelberg Germany
Université de Paris Paris France
University College Dublin School of Medicine Histopathology Dublin Ireland
University Hospital Antwerp Radiology Edegem Belgium
University Hospital of Salamanca Thoracic Surgery Salamanca Spain
University Hospitals Leuven Thoracic Surgery Leuven Belgium
University of Heidelberg Diagnostic and Interventional Radiology Heidelberg Germany
University of Latvia Faculty of Medicine Riga Latvia
University of Nottingham Faculty of Medicine and Health Sciences Nottingham UK
References provided by Crossref.org
